We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Working against a disease with no available vaccines, PaxVax has picked up an important regulatory boost from the FDA for its Chikungunya shot. The agency blessed the candidate with its Fast Track Designation...